Abstract
Background: Findings on the association between the insertion/deletion (I/D) polymorphism of the angiotensin I-converting enzyme (ACE) gene and cardiovascular morbidity and mortality have been inconsistent. Considering the possible interaction between this polymorphism and smoking, we evaluated the association between ACE I/D polymorphism and myocardial infarction (MI), mortality due to coronary heart disease (CHD), and cardiovascular disease (CVD).
Methods: The study was performed within the Rotterdam Study, a population based cohort study. The ACE I/D polymorphism was determined for 6714 participants and smoking status recorded at baseline. Fatal and non-fatal MIs and mortality events were regularly recorded. Cox proportional hazard analysis was performed separately for current smokers and non-smokers. We used age as the follow up time, presenting age specific survivals.
Results: During follow up, 248 MIs and 301 and 482 deaths, respectively, due to CHD and CVD occurred. There were no significant differences between the genotypes as regards MI incidence. Among smokers, there was an increased risk of CHD and CVD mortality in carriers of the DD genotype compared to the II genotype, which diminished at later ages (p<0.01 for gene-age interaction). Subgroup analysis in a younger and older group (based on the median age of 68.2 years) showed a significantly increased risk of CVD mortality in the younger group (hazard ratio = 5.19; 95% confidence interval: 1.15 to 23.42).
Conclusions: This study showed that the ACE I/D polymorphism is not a strong risk factor for MI but its interaction with smoking might play a role in cardiovascular mortality especially at younger ages.
Full Text
The Full Text of this article is available as a PDF (77.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Agerholm-Larsen B., Nordestgaard B. G., Steffensen R., Sørensen T. I., Jensen G., Tybjaerg-Hansen A. ACE gene polymorphism: ischemic heart disease and longevity in 10,150 individuals. A case-referent and retrospective cohort study based on the Copenhagen City Heart Study. Circulation. 1997 May 20;95(10):2358–2367. doi: 10.1161/01.cir.95.10.2358. [DOI] [PubMed] [Google Scholar]
- Agerholm-Larsen B., Nordestgaard B. G., Tybjaerg-Hansen A. ACE gene polymorphism in cardiovascular disease: meta-analyses of small and large studies in whites. Arterioscler Thromb Vasc Biol. 2000 Feb;20(2):484–492. doi: 10.1161/01.atv.20.2.484. [DOI] [PubMed] [Google Scholar]
- Berk B. C., Vekshtein V., Gordon H. M., Tsuda T. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension. 1989 Apr;13(4):305–314. doi: 10.1161/01.hyp.13.4.305. [DOI] [PubMed] [Google Scholar]
- Brull D. J., Sanders J., Rumley A., Lowe G. D., Humphries S. E., Montgomery H. E. Impact of angiotensin converting enzyme inhibition on post-coronary artery bypass interleukin 6 release. Heart. 2002 Mar;87(3):252–255. doi: 10.1136/heart.87.3.252. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Buikema H., Pinto Y. M., Rooks G., Grandjean J. G., Schunkert H., van Gilst W. H. The deletion polymorphism of the angiotensin-converting enzyme gene is related to phenotypic differences in human arteries. Eur Heart J. 1996 May;17(5):787–794. doi: 10.1093/oxfordjournals.eurheartj.a014947. [DOI] [PubMed] [Google Scholar]
- Cambien F., Poirier O., Lecerf L., Evans A., Cambou J. P., Arveiler D., Luc G., Bard J. M., Bara L., Ricard S. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992 Oct 15;359(6396):641–644. doi: 10.1038/359641a0. [DOI] [PubMed] [Google Scholar]
- Evans A. E., Poirier O., Kee F., Lecerf L., McCrum E., Falconer T., Crane J., O'Rourke D. F., Cambien F. Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease. Q J Med. 1994 Apr;87(4):211–214. [PubMed] [Google Scholar]
- Hibi K., Ishigami T., Kimura K., Nakao M., Iwamoto T., Tamura K., Nemoto T., Shimizu T., Mochida Y., Ochiai H. Angiotensin-converting enzyme gene polymorphism adds risk for the severity of coronary atherosclerosis in smokers. Hypertension. 1997 Sep;30(3 Pt 2):574–579. doi: 10.1161/01.hyp.30.3.574. [DOI] [PubMed] [Google Scholar]
- Hofman A., Grobbee D. E., de Jong P. T., van den Ouweland F. A. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol. 1991 Jul;7(4):403–422. doi: 10.1007/BF00145007. [DOI] [PubMed] [Google Scholar]
- Holmer Stephan R., Bickeböller Heike, Hengstenberg Christian, Rohlmann Friederike, Engel Susanne, Löwel Hannelore, Mayer Björn, Erdmann Jeannette, Baier Christian, Klein Gernot. Angiotensin converting enzyme gene polymorphism and myocardial infarction a large association and linkage study. Int J Biochem Cell Biol. 2003 Jun;35(6):955–962. doi: 10.1016/s1357-2725(02)00261-3. [DOI] [PubMed] [Google Scholar]
- Ilveskoski E., Perola M., Lehtimäki T., Laippala P., Savolainen V., Pajarinen J., Penttilä A., Lalu K. H., Männikkö A., Liesto K. K. Age-dependent association of apolipoprotein E genotype with coronary and aortic atherosclerosis in middle-aged men: an autopsy study. Circulation. 1999 Aug 10;100(6):608–613. doi: 10.1161/01.cir.100.6.608. [DOI] [PubMed] [Google Scholar]
- Lindpaintner K., Pfeffer M. A., Kreutz R., Stampfer M. J., Grodstein F., LaMotte F., Buring J., Hennekens C. H. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med. 1995 Mar 16;332(11):706–711. doi: 10.1056/NEJM199503163321103. [DOI] [PubMed] [Google Scholar]
- Mattace-Raso Francesco U. S., van der Cammen Tischa J. M., Sayed-Tabatabaei Fakhredin A., van Popele Nicole M., Asmar Roland, Schalekamp Maarten A. D. H., Hofman Albert, van Duijn Cornelia M., Witteman Jacqueline C. M. Angiotensin-converting enzyme gene polymorphism and common carotid stiffness. The Rotterdam study. Atherosclerosis. 2004 May;174(1):121–126. doi: 10.1016/j.atherosclerosis.2004.01.012. [DOI] [PubMed] [Google Scholar]
- Mattu R. K., Needham E. W., Galton D. J., Frangos E., Clark A. J., Caulfield M. A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart Study. Circulation. 1995 Jan 15;91(2):270–274. doi: 10.1161/01.cir.91.2.270. [DOI] [PubMed] [Google Scholar]
- Miller S. A., Dykes D. D., Polesky H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988 Feb 11;16(3):1215–1215. doi: 10.1093/nar/16.3.1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nakai K., Itoh C., Miura Y., Hotta K., Musha T., Itoh T., Miyakawa T., Iwasaki R., Hiramori K. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation. 1994 Nov;90(5):2199–2202. doi: 10.1161/01.cir.90.5.2199. [DOI] [PubMed] [Google Scholar]
- Patel M. K., Betteridge L. J., Hughes A. D., Clunn G. F., Schachter M., Shaw R. J., Sever P. S. Effect of angiotension II on the expression of the early growth response gene c-fos and DNA synthesis in human vascular smooth muscle cells. J Hypertens. 1996 Mar;14(3):341–347. doi: 10.1097/00004872-199603000-00011. [DOI] [PubMed] [Google Scholar]
- Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990 Oct;86(4):1343–1346. doi: 10.1172/JCI114844. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Samani N. J., Thompson J. R., O'Toole L., Channer K., Woods K. L. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation. 1996 Aug 15;94(4):708–712. doi: 10.1161/01.cir.94.4.708. [DOI] [PubMed] [Google Scholar]
- Sayed-Tabatabaei F. A., Schut A. F. C., Hofman A., Bertoli-Avella A. M., Vergeer J., Witteman J. C. M., van Duijn C. M. A study of gene--environment interaction on the gene for angiotensin converting enzyme: a combined functional and population based approach. J Med Genet. 2004 Feb;41(2):99–103. doi: 10.1136/jmg.2003.013441. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schut Anna F. C., Sayed-Tabatabaei Fakhredin A., Witteman Jacqueline C. M., Avella Aida M. Bertoli, Vergeer Jeannette M., Pols Huibert A. P., Hofman Albert, Deinum Jaap, van Duijn Cornelia M. Smoking-dependent effects of the angiotensin-converting enzyme gene insertion/deletion polymorphism on blood pressure. J Hypertens. 2004 Feb;22(2):313–319. doi: 10.1097/00004872-200402000-00015. [DOI] [PubMed] [Google Scholar]
- Slooter A. J., Cruts M., Van Broeckhoven C., Hofman A., van Duijin C. M. Apolipoprotein E and longevity: the Rotterdam Study. J Am Geriatr Soc. 2001 Sep;49(9):1258–1259. doi: 10.1046/j.1532-5415.2001.49251.x. [DOI] [PubMed] [Google Scholar]
- Sugiyama Y., Yotsumoto H., Okabe T., Takaku F. Measurement of angiotensin-converting enzyme activity in intact human alveolar macrophages and effect of smoking. Respiration. 1988;53(3):153–157. doi: 10.1159/000195408. [DOI] [PubMed] [Google Scholar]
- Ueda S., Elliott H. L., Morton J. J., Connell J. M. Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension. 1995 Jun;25(6):1266–1269. doi: 10.1161/01.hyp.25.6.1266. [DOI] [PubMed] [Google Scholar]
- Zhang S., Day I., Ye S. Nicotine induced changes in gene expression by human coronary artery endothelial cells. Atherosclerosis. 2001 Feb 1;154(2):277–283. doi: 10.1016/s0021-9150(00)00475-5. [DOI] [PubMed] [Google Scholar]